Peter Sandys is Chairman of Seroba Life Sciences. He was a co-founder of Seroba, acting as Managing Partner until 2021 when he transitioned to the role of Chairman.
Peter has held many directorships in the fund management, technology and financial services industries. He was previously Managing Director of ABN Amro Corporate Finance (Ireland) Limited where he had responsibility for the firm’s capital markets and venture capital businesses. Prior to joining ABN Amro, Peter worked in Corporate Advisory Services for Ernst & Young (E&Y) in London and Dublin. During this period, Peter was also seconded to 3i venture capital. Prior to joining E&Y, he worked for KPMG.
Peter has a BBS degree from TCD and is a Chartered Accountant. He has served twice as Chairman of the Irish Venture Capital Association and was a member of the Irish Stock Exchange’s New Issues Committee and the committee of the Irish Bio Industries Association. He was also formerly a member of the Securities Institute, a Registered Stockbroker and a member of the Institute of Taxation in Ireland. Peter sits on the board of Quanta Dialysis Technologies and was previously on the board of PrecisionBiotics (acquired by Novozymes.)